Roundview Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$237K Sell
2,784
-400
-13% -$35.6K 0.01% 321
2025
Q4
$252K Sell
3,184
-380
-11% -$29.8K 0.02% 304
2025
Q3
$285K Hold
3,564
0.02% 303
2025
Q2
$324K Buy
3,564
+35
+1% +$3.19K 0.02% 283
2025
Q1
$331K Sell
3,529
-194
-5% -$17.4K 0.02% 276
2024
Q4
$338K Buy
3,723
+962
+35% +$91.8K 0.02% 292
2024
Q3
$287K Buy
2,761
+170
+7% +$17.3K 0.02% 305
2024
Q2
$251K Buy
2,591
+55
+2% +$5.07K 0.02% 302
2024
Q1
$228K Buy
+2,536
New +$215K 0.02% 300
2022
Q1
Sell
-2,467
Closed -$211K 296
2021
Q4
$211K Buy
+2,467
New +$193K 0.02% 291

Other funds holding CL

Roundview Capital's CL Position: Q1 2026 in Review

Roundview Capital reduced its Colgate-Palmolive (CL) stake by 13% in Q1 2026, selling an estimated $35.6K and leaving 2,784 shares worth $237K. The position accounts for 0.01% of the portfolio, ranked #321.

Roundview Capital first reported a position in CL in Q4 2021 and has held it in 10 quarters since. The position peaked at $338K in Q4 2024. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Roundview Capital held 2,784 shares of Colgate-Palmolive worth $237K as of Q1 2026.
  • Roundview Capital sold 400 Colgate-Palmolive shares in Q1 2026, an estimated $35.6K.
  • Colgate-Palmolive made up 0.01% of Roundview Capital's portfolio in Q1 2026, its #321 holding.
  • Roundview Capital first reported a position in Colgate-Palmolive in Q4 2021 and has held it in 10 quarters since.
  • Roundview Capital's Colgate-Palmolive position peaked at $338K in Q4 2024.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Roundview Capital's 13F filing for Q1 2026, filed 8 May 2026.